Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kulvinder Kaur

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Genetics|May 8, 2012
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1Emma Jaeger, Simon Leedham, Annabelle Lewis, et al.
Human Molecular Genetics|March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancerDavid N Church, Sarah E W Briggs, Claire Palles, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
The Journal of Investigative Dermatology|March 21, 2024
Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed SkinKulvinder Kaur, Rizi Ai, Allyson G Perry, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screenDebora Bogani, Catherine Willoughby, Jennifer Davies, et al.
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Genes & Development|June 4, 2008
VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5Dorota Szumska, Guido Pieles, Rachid Essalmani, et al.
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Genetics|December 25, 2012
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomasClaire Palles, Jean-Baptiste Cazier, Kimberley M Howarth, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Genetics|May 8, 2012
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1Emma Jaeger, Simon Leedham, Annabelle Lewis, et al.
Human Molecular Genetics|March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancerDavid N Church, Sarah E W Briggs, Claire Palles, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
The Journal of Investigative Dermatology|March 21, 2024
Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed SkinKulvinder Kaur, Rizi Ai, Allyson G Perry, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screenDebora Bogani, Catherine Willoughby, Jennifer Davies, et al.
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Genes & Development|June 4, 2008
VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5Dorota Szumska, Guido Pieles, Rachid Essalmani, et al.
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Genetics|December 25, 2012
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomasClaire Palles, Jean-Baptiste Cazier, Kimberley M Howarth, et al.
Pageof 2